Study NCT00565292
Information provided by Merck
First Received: November 27, 2007
No Changes Posted
| This study has been completed. |
|
August 2006
|
|
No date given
|
No publications provided by Merck
Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):
Krishna R, Anderson MS, Bergman AJ, Jin B, Fallon M, Cote J, Rosko K, Chavez-Eng C, Lutz R, Bloomfield DM, Gutierrez M, Doherty J, Bieberdorf F, Chodakewitz J, Gottesdiener KM, Wagner JA. Effect of the cholesteryl ester transfer protein inhibitor, anacetrapib, on lipoproteins in patients with dyslipidaemia and on 24-h ambulatory blood pressure in healthy individuals: two double-blind, randomised placebo-controlled phase I studies. Lancet. 2007 Dec 8;370(9603):1907-14.